Site 0173 - Mount Sinai Medical Center — Miami Beach, Florida

Site 0173 - Mount Sinai Medical Center is a clinical research site located in Miami Beach, Florida, United States 33140.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site 0173 - Mount Sinai Medical Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Sponsors: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Miami Beach

Browse all research sites in Florida · View every site in Miami Beach

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 0173 - Mount Sinai Medical Center?

Site 0173 - Mount Sinai Medical Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 0173 - Mount Sinai Medical Center conducted?

Site 0173 - Mount Sinai Medical Center has 1 clinical trials on record, with 1 currently active. Their work covers High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Is Site 0173 - Mount Sinai Medical Center accredited by Crixeo Clinical Trials?

Site 0173 - Mount Sinai Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 0173 - Mount Sinai Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.